Paclitaxel-Albumin Zentiva 100 mg
Paclitaxel-Albumin Zentiva 100 mg is a medicine authorised by Swissmedic under authorisation number 70436. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 07 July 2026 and the authorisation is limited until 06 July 2031. ATC code L01CD01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70436 |
|---|---|
| Name | Paclitaxel-Albumin Zentiva 100 mg |
| Full name | Paclitaxel-Albumin Zentiva 100 mg, Pulver zur Herstellung einer Infusionsdispersion |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CD01 |
| First authorisation | 07 July 2026 |
| Authorisation validity | 06 July 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Paclitaxel-Albumin Zentiva 100 mg, Pulver zur Herstellung einer Infusionsdispersion | A | 07 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01CD01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Paclitaxel-Albumin Zentiva 100 mg authorised in Switzerland?
Yes. Paclitaxel-Albumin Zentiva 100 mg is authorised by Swissmedic under authorisation number 70436, data as of 01 September 2026. The authorisation is limited until 06 July 2031.
Which dispensing category does Paclitaxel-Albumin Zentiva 100 mg have?
Paclitaxel-Albumin Zentiva 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Paclitaxel-Albumin Zentiva 100 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.